Home Healthcare Pharmaceuticals Antibiotics Market

Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, Other), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Antibiotics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Cephalosporin
    2. Penicillin
    3. Fluoroquinolone
    4. Macrolides
    5. Carbapenem
    6. Aminoglycosides
    7. Sulfonamides
    8. Other
  2. Antibiotics Market, By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
    1. Broad-spectrum Antibiotic
    2. Narrow-spectrum Antibiotic
  3. Regional Antibiotics Market
    1. North America
      1. North America Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. North America Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. U.S.
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      4. Canada
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
    2. Europe
      1. Europe Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. Europe Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. U.K.
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      4. Germany
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      5. France
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      6. Spain
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      7. Italy
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      8. Russia
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      9. Nordic
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      10. Benelux
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      11. Rest of Europe
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
    3. APAC
      1. APAC Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. APAC Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. China
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      4. Korea
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      5. Japan
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      6. India
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      7. Australia
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      8. Taiwan
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      9. South East Asia
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      10. Rest of Asia-Pacific
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
    4. Middle East and Africa
      1. Middle East and Africa Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. Middle East and Africa Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. UAE
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      4. Turkey
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      5. Saudi Arabia
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      6. South Africa
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      7. Egypt
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      8. Nigeria
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      9. Rest of MEA
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
    5. LATAM
      1. LATAM Antibiotics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
      2. LATAM Antibiotics Market By Spectrum of Activity 2022-2034 (USD MILLION/ Units)
        1. Broad-spectrum Antibiotic
        2. Narrow-spectrum Antibiotic
      3. Brazil
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      4. Mexico
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      5. Argentina
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      6. Chile
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      7. Colombia
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
      8. Rest of LATAM
        1. Cephalosporin
        2. Penicillin
        3. Fluoroquinolone
        4. Macrolides
        5. Carbapenem
        6. Aminoglycosides
        7. Sulfonamides
        8. Other
        9. Broad-spectrum Antibiotic
        10. Narrow-spectrum Antibiotic
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.